Literature DB >> 21839334

Development of myelodysplastic syndrome evolving to acute myeloid leukemia in a patient receiving etanercept for psoriasis.

Richelle M Knudson1, Ayalew Tefferi2, Mark R Pittelkow1, Mark D P Davis3.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21839334     DOI： 10.1016/j.jaad.2010.06.049

Source DB:  PubMed          Journal:  J Am Acad Dermatol        ISSN： 0190-9622            Impact factor:   11.527


× No keyword cloud information.
  4 in total

1.  Leukaemic transformation in patients with haematological disease receiving tumour necrosis factor inhibitors.

Authors:  Francisca Ferrer-Marín; Maria Luz Amigo; Vicente Vicente
Journal:  Clin Drug Investig       Date:  2012-06-01       Impact factor: 2.859

Review 2.  Etanercept-induced leukemia: could increased mean corpuscular volume be a predictor of hematologic malignancy?

Authors:  Döndü Üsküdar Cansu; Hava Üsküdar Teke; Cengiz Korkmaz
Journal:  Rheumatol Int       Date:  2017-03-02       Impact factor: 2.631

3.  A child with psoriasis, hypogammaglobulinemia, and monosomy 7-positive myelodysplastic syndrome.

Authors:  Namık Özbek; Arzu Yazal Erdem; Özlem Arman Bilir; Fatma Karaca Kara; Mutlu Yüksek; Neşe Yaralı; Meltem Özgüner; Nazmiye Yüksek; Bahattin Tunç
Journal:  Turk J Haematol       Date:  2015-03-05       Impact factor: 1.831

4.  Psoriasis vulgaris and familial cancer risk- a population-based study.

Authors:  Romuald Maleszka; Katarzyna Paszkowska-Szczur; Ewa Soczawa; Magdalena Boer; Monika Różewicka-Czabańska; Joanna Wiśniewska; Aneta Mirecka; Lidia Krysztoforska; Zygmunt Adamski; Jan Lubinski; Tadeusz Dębniak
Journal:  Hered Cancer Clin Pract       Date:  2013-06-28       Impact factor: 2.857
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.